KalVista Pharmaceuticals enters lease for HQ and lab in Framingham; aggregate rent ~$11.2M

KalVista Pharmaceuticals, Inc.

Lease for 32,110 sq ft at 200 Crossing Blvd, Framingham, MA, as corporate HQ and lab space.
Commencement on or about April 30, 2025; lease expires December 31, 2034.
Aggregate base rent payments of approximately $11.2 million over the term.
Security deposit of ~$652,800 in the form of a letter of credit.
Company to pay pro rata share of operating expenses and certain taxes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.